Nanofiber Scaffold-Based Tissue Engineering for the Treatment of Acute Liver Failure
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Liver physiology and pathology · Tissue Engineering and Regenerative Medicine · Anesthesia and Neurotoxicity Research
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (100+)
Show source-provided references
1. Tong XF, Zhao FQ, Ren YZ, Zhang Y, Cui YL, Wang QS. Injectable hydrogels based on glycyrrhizin, alginate, and calcium for three-dimensional cell culture in liver tissue engineering. J Biomed Mater Res A. 2018;106:3292.10.1002/jbm.a.36528 ↗
2. Si-Tayeb K, Lemaigre FP, Duncan SA. Organogenesis and development of the liver. Dev Cell. 2010;18:175.10.1016/j.devcel.2010.01.011 ↗
3. Jiang H, Yan R, Wang K, Wang Q, Chen X, Chen L, Li L, Lv L. Lactobacillus reuteri DSM 17938 alleviates d-galactosamine-induced liver failure in rats. Biomed Pharmacother. 2021;133: 111000.10.1016/j.biopha.2020.111000 ↗
4. Wijdicks EF. Hepatic encephalopathy. N Engl J Med. 2016;375:1660.10.1056/NEJMra1600561 ↗
5. Thanapirom K, Treeprasertsuk S, Soonthornworasiri N, Poovorawan K, Chaiteerakij R, Komolmit P, Phaosawasdi K, Pinzani M. The incidence, etiologies, outcomes, and predictors of mortality of acute liver failure in Thailand: a population-base study. BMC Gastroenterol. 2019;19:18.10.1186/s12876-019-0935-y ↗
6. Dutkowski P, Linecker M, Deoliveira ML, Mullhaupt B, Clavien PA. Challenges to liver transplantation and strategies to improve outcomes. Gastroenterology. 2015;148:307.10.1053/j.gastro.2014.08.045 ↗
7. Ozden I, Yavru HA, Durmaz O, Orhun G, Salmaslioglu A, Gulluoglu M, Alper A, Ibis C, Serin KR, Onal Z, Ozcan PE, Poyanli A, Hancerli S, Cagatay A, Cantez S, Kaymakoglu S. Complementary roles of cadaveric and living donor liver transplantation in acute liver failure. J Gastrointest Surg. 2021;25:2516.10.1007/s11605-021-04932-3 ↗
8. Collin De L’hortet A, Takeishi K, Guzman-Lepe J, Handa K, Matsubara K, Fukumitsu K, Dorko K, Presnell SC, Yagi H, Soto-Gutierrez A. Liver-regenerative transplantation: regrow and reset. Am J Transplant. 2016;16:1688.10.1111/ajt.13678 ↗
9. Kwong A, Kim WR, Lake JR, Smith JM, Schladt DP, Skeans MA, Noreen SM, Foutz J, Miller E, Snyder JJ, Israni AK, Kasiske BL. OPTN/SRTR 2018 annual data report: liver. Am J Transplant. 2020;20:193.10.1111/ajt.15674 ↗
10. Hou YT, Hsu CC. Development of a 3D porous chitosan/gelatin liver scaffold for a bioartificial liver device. J Biosci Bioeng. 2020;129:741.10.1016/j.jbiosc.2019.12.012 ↗
11. Pareja E, Gomez-Lechon MJ, Cortes M, Bonora-Centelles A, Castell JV, Mir J. Human hepatocyte transplantation in patients with hepatic failure awaiting a graft. Eur Surg Res. 2013;50:273.10.1159/000351332 ↗
12. Nicolas CT, Kaiser RA, Hickey RD, Allen KL, Du Z, Vanlith CJ, Guthman RM, Amiot B, Suksanpaisan L, Han B, Francipane MG, Cheikhi A, Jiang H, Bansal A, Pandey MK, Garg I, Lowe V, Bhagwate A, Orien D, Kocher JA, Degrado TR, Nyberg SL, Lagasse E, Lillegard JB. Ex vivo cell therapy by ectopic hepatocyte transplantation treats the porcine tyrosinemia model of acute liver failure. Mol Ther Methods Clin Dev. 2020;18:738.10.1016/j.omtm.2020.07.009 ↗
13. Bhatia SN, Underhill GH, Zaret KS, Fox IJ. Cell and tissue engineering for liver disease. Sci Transl Med. 2014;6:245sr2.10.1126/scitranslmed.3005975 ↗
14. Sakai Y, Yamanouchi K, Ohashi K, Koike M, Utoh R, Hasegawa H, Muraoka I, Suematsu T, Soyama A, Hidaka M, Takatsuki M, Kuroki T, Eguchi S. Vascularized subcutaneous human liver tissue from engineered hepatocyte/fibroblast sheets in mice. Biomaterials. 2015;65:66.10.1016/j.biomaterials.2015.06.046 ↗
15. Saadi T, Nayshool O, Carmel J, Ariche A, Bramnik Z, Mironi-Harpaz I, Seliktar D, Baruch Y. Cellularized biosynthetic microhydrogel polymers for intravascular liver tissue regeneration therapy. Tissue Eng Part A. 2014;20:2850.10.1089/ten.tea.2013.0494 ↗
16. Ye S, Boeter JWB, Penning LC, Spee B, Schneeberger K. Hydrogels for liver tissue engineering. Bioengineering. 2019;6:59.10.3390/bioengineering6030059 ↗
17. Heydari Z, Najimi M, Mirzaei H, Shpichka A, Ruoss M, Farzaneh Z, Montazeri L, Piryaei A, Timashev P, Gramignoli R, Nussler A, Baharvand H, Vosough M. Tissue engineering in liver regenerative medicine: insights into novel translational technologies. Cells. 2020;9:304.10.3390/cells9020304 ↗
18. Mazza G, Al-Akkad W, Rombouts K, Pinzani M. Liver tissue engineering: from implantable tissue to whole organ engineering. Hepatol Commun. 2018;2:131.10.1002/hep4.1136 ↗
19. Mirdamadi ES, Kalhori D, Zakeri N, Azarpira N, Solati-Hashjin M. Liver tissue engineering as an emerging alternative for liver disease treatment. Tissue Eng Part B Rev. 2020;26:145.10.1089/ten.teb.2019.0233 ↗
20. Das P, Divito MD, Wertheim JA, Tan LP. Collagen-I and fibronectin modified three-dimensional electrospun PLGA scaffolds for long-term in vitro maintenance of functional hepatocytes. Mat Sci Eng C-Mater. 2020;111: 110723.10.1016/j.msec.2020.110723 ↗
21. Zhang MM, Xu SX, Wang RY, Che YA, Han CC, Feng W, Wang CW, Zhao W. Electrospun nanofiber/hydrogel composite materials and their tissue engineering applications. J Mater Sci Technol. 2023;162:157.10.1016/j.jmst.2023.04.015 ↗
22. Li G, Chen K, You D, Xia M, Li W, Fan S, Chai R, Zhang Y, Li H, Sun S. Laminin-coated electrospun regenerated silk fibroin mats promote neural progenitor cell proliferation, differentiation, and survival in vitro. Front Bioeng Biotechnol. 2019;7:190.10.3389/fbioe.2019.00190 ↗
23. Morelli S, Piscioneri A, Salerno S, De Bartolo L. Hollow fiber and nanofiber membranes in bioartificial liver and neuronal tissue engineering. Cells Tissues Organs. 2022;211:447.
24. Yen CM, Shen CC, Yang YC, Liu BS, Lee HT, Sheu ML, Tsai MH, Cheng WY. Novel electrospun poly(epsilon-caprolactone)/type I collagen nanofiber conduits for repair of peripheral nerve injury. Neural Regen Res. 2019;14:1617.10.4103/1673-5374.255997 ↗
25. Sarhane KA, Ibrahim Z, Martin R, Krick K, Cashman CR, Tuffaha SH, Broyles JM, Prasad N, Yao ZC, Cooney DS, Mi R, Lee WA, Hoke A, Mao HQ, Brandacher G. Macroporous nanofiber wraps promote axonal regeneration and functional recovery in nerve repair by limiting fibrosis. Acta Biomater. 2019;88:332.10.1016/j.actbio.2019.02.034 ↗
26. Mao RY, Yu B, Cui JJ, Wang ZY, Huang XT, Yu HB, Lin KL, Shen SGF. Piezoelectric stimulation from electrospun composite nanofibers for rapid peripheral nerve regeneration. Nano Energy. 2022;98: 107322.10.1016/j.nanoen.2022.107322 ↗
27. Niu Y, Galluzzi M, Deng F, Zhao Z, Fu M, Su L, Sun W, Jia W, Xia H. A biomimetic hyaluronic acid-silk fibroin nanofiber scaffold promoting regeneration of transected urothelium. Bioeng Transl Med. 2022;7: e10268.10.1002/btm2.10268 ↗
28. Niu YQ, Liu GC, Fu M, Chen CB, Fu W, Zhang Z, Xia HM, Stadler FJ. Designing a multifaceted bio-interface nanofiber tissue-engineered tubular scaffold graft to promote neo-vascularization for urethral regeneration. J Mater Chem B. 2020;8:1748.10.1039/C9TB01915D ↗
29. Niu Y, Stadler FJ, Yang X, Deng F, Liu G, Xia H. HA-coated collagen nanofibers for urethral regeneration via in situ polarization of M2 macrophages. J Nanobiotechnol. 2021;19:283.10.1186/s12951-021-01000-5 ↗
30. Yoon JY, Mandakhbayar N, Hyun J, Yoon DS, Patel KD, Kang K, Shim HS, Lee HH, Lee JH, Leong KW, Kim HW. Chemically-induced osteogenic cells for bone tissue engineering and disease modeling. Biomaterials. 2022;289: 121792.10.1016/j.biomaterials.2022.121792 ↗
31. Wang X, Peng Y, Wu Y, Cao S, Deng H, Cao Z. Chitosan/silk fibroin composite bilayer PCL nanofibrous mats for bone regeneration with enhanced antibacterial properties and improved osteogenic potential. Int J Biol Macromol. 2023;230: 123265.10.1016/j.ijbiomac.2023.123265 ↗
32. Zhang X, Li Q, Li L, Ouyang J, Wang T, Chen J, Hu X, Ao Y, Qin D, Zhang L, Xue J, Cheng J, Tao W. Bioinspired mild photothermal effect-reinforced multifunctional fiber scaffolds promote bone regeneration. ACS Nano. 2023;17:6466.10.1021/acsnano.2c11486 ↗
33. Jin QH, Fu Y, Zhang GL, Xu L, Jin GZ, Tang LF, Ju JH, Zhao WX, Hou RX. Nanofiber electrospinning combined with rotary bioprinting for fabricating small-diameter vessels with endothelium and smooth muscle. Compos Part B-Eng. 2022;234: 109691.10.1016/j.compositesb.2022.109691 ↗
34. Han FX, Jia XL, Dai DD, Yang XL, Zhao J, Zhao YH, Fan YB, Yuan XY. Performance of a multilayered small-diameter vascular scaffold dual-loaded with VEGF and PDGF. Biomaterials. 2013;34:7302.10.1016/j.biomaterials.2013.06.006 ↗
35. Wu T, Zhang JL, Wang YF, Li DD, Sun BB, El-Hamshary H, Yin M, Mo XM. Fabrication and preliminary study of a biomimetic tri-layer tubular graft based on fibers and fiber yarns for vascular tissue engineering. Mat Sci Eng C-Mater. 2018;82:121.10.1016/j.msec.2017.08.072 ↗
36. Xi YW, Ge J, Guo Y, Lei B, Ma PX. Biomimetic elastomeric polypeptide-based nanofibrous matrix for overcoming multidrug-resistant bacteria and enhancing full-thickness wound healing/skin regeneration. ACS Nano. 2018;12:10772.10.1021/acsnano.8b01152 ↗
37. Sofi HS, Abdal-Hay A, Rashid R, Rafiq A, Rather S-U, Beigh MA, Alrokayan SH, Khan HA, Tripathi RM, Sheikh FA. Electrospun polyurethane fiber mats coated with fish collagen layer to improve cellular affinity for skin repair. Sustain Mater Technol. 2022;34: e00523.
38. Choi S, Raja IS, Selvaraj AR, Kang MS, Park T-E, Kim KS, Hyon S-H, Han D-W, Park J-C. Activated carbon nanofiber nanoparticles incorporated electrospun polycaprolactone scaffolds to promote fibroblast behaviors for application to skin tissue engineering. Adv Compos Hybrid Mater. 2022;6:24.10.1007/s42114-022-00608-x ↗
39. Yu CH, Wang TR, Diao HC, Liu N, Zhang Y, Jiang HY, Zhao P, Shan ZY, Sun ZW, Wu T, Mo XM, Yu TB. Photothermal-triggered structural change of nanofiber scaffold integrating with graded mineralization to promote tendon-bone healing. Adv Fiber Mater. 2022;4:908.10.1007/s42765-022-00154-7 ↗
40. Yang YT, Du YZ, Zhang J, Zhang HL, Guo BL. Structural and functional design of electrospun nanofibers for hemostasis and wound healing. Adv Fiber Mater. 2022;4:1027.10.1007/s42765-022-00178-z ↗
41. Dong YP, Zheng YQ, Zhang KY, Yao YM, Wang LH, Li XR, Yu JY, Ding B. Electrospun nanofibrous materials for wound healing. Adv Fiber Mater. 2020;2:212.10.1007/s42765-020-00034-y ↗
42. Slivac I, Zdraveva E, Ivancic F, Zunar B, Holjevac Grguric T, Gaurina Srcek V, Svetec IK, Dolenec T, Bajsic EG, Tominac Trcin M, Mijovic B. Bioactivity comparison of electrospun PCL mats and liver extracellular matrix as scaffolds for HepG2 cells. Polymers. 2021;13:279.10.3390/polym13020279 ↗
43. Ghahremanzadeh F, Alihosseini F, Semnani D. Investigation and comparison of new galactosylation methods on PCL/chitosan scaffolds for enhanced liver tissue engineering. Int J Biol Macromol. 2021;174:278.10.1016/j.ijbiomac.2021.01.158 ↗
44. Gao Y, Callanan A. Influence of surface topography on PCL electrospun scaffolds for liver tissue engineering. J Mater Chem B. 2021;9:8081.10.1039/D1TB00789K ↗
45. Navarro-Alvarez N, Soto-Gutierrez A, Chen Y, Caballero-Corbalan J, Hassan W, Kobayashi S, Kondo Y, Iwamuro M, Yamamoto K, Kondo E, Tanaka N, Fox IJ, Kobayashi N. Intramuscular transplantation of engineered hepatic tissue constructs corrects acute and chronic liver failure in mice. J Hepatol. 2010;52:211.10.1016/j.jhep.2009.11.019 ↗
46. Yu YQ, Jiang XS, Gao S, Ma R, Jin Y, Jin X, Peng SY, Mao HQ, Li JT. Local delivery of vascular endothelial growth factor via nanofiber matrix improves liver regeneration after extensive hepatectomy in rats. J Biomed Nanotechnol. 2014;10:3407.10.1166/jbn.2014.1872 ↗
47. Xu LJ, Wang SF, Su X, Wang Y, Su YN, Huang L, Zhang YW, Chen Z, Chen QQ, Du HT, Zhang YP, Yan L. Mesenchymal stem cell-seeded regenerated silk fibroin complex matrices for liver regeneration in an animal model of acute liver failure. ACS Appl Mater Inter. 2017;9:14716.10.1021/acsami.7b02805 ↗
48. Kim Y, Kim YW, Lee SB, Kang K, Yoon S, Choi D, Park SH, Jeong J. Hepatic patch by stacking patient-specific liver progenitor cell sheets formed on multiscale electrospun fibers promotes regenerative therapy for liver injury. Biomaterials. 2021;274: 120899.10.1016/j.biomaterials.2021.120899 ↗
49. Zhang L, Guan Z, Ye JS, Yin YF, Stoltz JF, De Isla N. Research progress in liver tissue engineering. Biomed Mater Eng. 2017;28:S113.
50. Liang S, Liang S, Yin N, Faiola F. Establishment of a human embryonic stem cell-based liver differentiation model for hepatotoxicity evaluations. Ecotoxicol Environ Saf. 2019;174:353.10.1016/j.ecoenv.2019.02.091 ↗
51. Foroutan T, Kassaee MZ, Salari M, Ahmady F, Molavi F, Moayer F. Magnetic Fe3O4 @graphene oxide improves the therapeutic effects of embryonic stem cells on acute liver damage. Cell Prolif. 2021;54: e13126.10.1111/cpr.13126 ↗
52. Zhang L, Ma XJ, Fei YY, Han HT, Xu J, Cheng L, Li X. Stem cell therapy in liver regeneration: focus on mesenchymal stem cells and induced pluripotent stem cells. Pharmacol Ther. 2022;232: 108004.10.1016/j.pharmthera.2021.108004 ↗
53. Chen S, Wang J, Ren H, Liu Y, Xiang C, Li C, Lu S, Shi Y, Deng H, Shi X. Hepatic spheroids derived from human induced pluripotent stem cells in bio-artificial liver rescue porcine acute liver failure. Cell Res. 2020;30:95.10.1038/s41422-019-0261-5 ↗
54. Bajek A, Gurtowska N, Olkowska J, Kazmierski L, Maj M, Drewa T. Adipose-derived stem cells as a tool in cell-based therapies. Arch Immunol Ther Exp. 2016;64:443.10.1007/s00005-016-0394-x ↗
55. Chan TM, Harn HJ, Lin HP, Chou PW, Chen JY, Ho TJ, Chiou TW, Chuang HM, Chiu SC, Chen YC, Yen SY, Huang MH, Liang BC, Lin SZ. Improved human mesenchymal stem cell isolation. Cell Transplant. 2014;23:399.10.3727/096368914X678292 ↗
56. Wei JJ, Tang L, Chen LL, Xie ZH, Ren Y, Qi HG, Lou JY, Weng GB, Zhang SW. Mesenchymal stem cells attenuates TGF-beta 1-induced EMT by increasing HGF expression in HK-2 cells. Iran J Public Health. 2021;50:908.
57. Liu WH, Song FQ, Ren LN, Guo WQ, Wang T, Feng YX, Tang LJ, Li K. The multiple functional roles of mesenchymal stem cells in participating in treating liver diseases. J Cell Mol Med. 2015;19:511.10.1111/jcmm.12482 ↗
58. Deng JJ, Wang X, Zhang WH, Sun LY, Han XX, Tong XQ, Yu LM, Ding JD, Yu L, Liu YH. Versatile hypoxic extracellular vesicles laden in an injectable and bioactive hydrogel for accelerated bone regeneration. Adv Funct Mater. 2023;33:2211664.10.1002/adfm.202211664 ↗
59. Wang Y, Yu X, Chen E, Li L. Liver-derived human mesenchymal stem cells: a novel therapeutic source for liver diseases. Stem Cell Res Ther. 2016;7:71.10.1186/s13287-016-0330-3 ↗
60. Lee H, Cusick RA, Browne F, Ho Kim T, Ma PX, Utsunomiya H, Langer R, Vacanti JP. Local delivery of basic fibroblast growth factor increases both angiogenesis and engraftment of hepatocytes in tissue-engineered polymer devices1. Transplantation. 2002;73:1589.10.1097/00007890-200205270-00011 ↗
61. Albrecht JH. MET and epidermal growth factor signaling: the pillars of liver regeneration? Hepatology. 2016;64:1427.10.1002/hep.28822 ↗
62. Shams S, Mohsin S, Nasir GA, Khan M, Khan SN. Mesenchymal stem cells pretreated with HGF and FGF4 can reduce liver fibrosis in mice. Stem Cells Int. 2015;2015: 747245.10.1155/2015/747245 ↗
63. Jayalakshmi VT, Bernal W. Update on the management of acute liver failure. Curr Opin Crit Care. 2020;26:163.10.1097/MCC.0000000000000697 ↗
64. Zhan C, Lin G, Huang Y, Wang Z, Zeng F, Wu S. A dopamine-precursor-based nanoprodrug for in-situ drug release and treatment of acute liver failure by inhibiting NLRP3 inflammasome and facilitating liver regeneration. Biomaterials. 2021;268: 120573.10.1016/j.biomaterials.2020.120573 ↗
65. Rodgers SK, Horrow MM. Acute (fulminant) liver failure: a clinical and imaging review. Abdom Radiol. 2021;46:3117.10.1007/s00261-021-02973-5 ↗
66. Lou G, Li A, Cen Y, Yang Q, Zhang T, Qi J, Chen Z, Liu Y. Selonsertib, a potential drug for liver failure therapy by rescuing the mitochondrial dysfunction of macrophage via ASK1-JNK-DRP1 pathway. Cell Biosci. 2021;11:9.10.1186/s13578-020-00525-w ↗
67. Zeng Y, Wu R, Wang F, Li S, Li L, Li Y, Qin P, Wei M, Yang J, Wu J, Chen A, Ke G, Yan Z, Yang H, Chen Z, Wang Z, Xiao W, Jiang Y, Chen X, Zeng Z, Zhao X, Chen P, Gong S. Liberation of daidzein by gut microbial beta-galactosidase suppresses acetaminophen-induced hepatotoxicity in mice. Cell Host Microbe. 2023;31:766.10.1016/j.chom.2023.04.002 ↗
68. Chowdhury A, Nabila J, Adelusi Temitope I, Wang S. Current etiological comprehension and therapeutic targets of acetaminophen-induced hepatotoxicity. Pharmacol Res. 2020;161: 105102.10.1016/j.phrs.2020.105102 ↗
69. Cai X, Cai H, Wang J, Yang Q, Guan J, Deng J, Chen Z. Molecular pathogenesis of acetaminophen-induced liver injury and its treatment options. J Zhejiang Univ Sci B. 2022;23:265.10.1631/jzus.B2100977 ↗
70. Bernal W, Wendon J. Acute liver failure. N Engl J Med. 2013;369:2525.10.1056/NEJMra1208937 ↗
71. Kim JD, Cho EJ, Ahn C, Park SK, Choi JY, Lee HC, Kim DY, Choi MS, Wang HJ, Kim IH, Yeon JE, Seo YS, Tak WY, Kim MY, Lee HJ, Kim YS, Jun DW, Sohn JH, Kwon SY, Park SH, Heo J, Jeong SH, Lee JH, Nakayama N, Mochida S, Ido A, Tsubouchi H, Takikawa H, Shalimar, Acharya SK, Bernal W, O’grady J, Kim YJ. A model to predict 1-month risk of transplant or death in hepatitis A-related acute liver failure. Hepatology. 2019;70:621.10.1002/hep.30262 ↗
72. Moretto F, Catherine FX, Esteve C, Blot M, Piroth L. Isolated anti-HBc: significance and management. J Clin Med. 2020;9:202.10.3390/jcm9010202 ↗
73. Laumon T, Dietrich H, Muller L, Roger C. Acute liver failure and misdiagnosis: do not forget viral hepatitis E. Anaesth Crit Care Pain Med. 2019;38:73.10.1016/j.accpm.2018.06.001 ↗
74. Taylor RM, Tujios S, Jinjuvadia K, Davern T, Shaikh OS, Han S, Chung RT, Lee WM, Fontana RJ. Short and long-term outcomes in patients with acute liver failure due to ischemic hepatitis. Dig Dis Sci. 2012;57:777.10.1007/s10620-011-1918-1 ↗
75. Tapper EB, Sengupta N, Bonder A. The incidence and outcomes of ischemic hepatitis: a systematic review with meta-analysis. Am J Med. 2015;128:1314.10.1016/j.amjmed.2015.07.033 ↗
76. Buechter M, Manka P, Heinemann FM, Lindemann M, Baba HA, Schlattjan M, Canbay A, Gerken G, Kahraman A. Potential triggering factors of acute liver failure as a first manifestation of autoimmune hepatitis-a single center experience of 52 adult patients. World J Gastroenterol. 2018;24:1410.10.3748/wjg.v24.i13.1410 ↗
77. Chalasani N, Bonkovsky HL, Fontana R, Lee W, Stolz A, Talwalkar J, Reddy KR, Watkins PB, Navarro V, Barnhart H, Gu J, Serrano J, United States Drug Induced Liver Injury Network. Features and outcomes of 899 patients with drug-induced liver injury: the DILIN prospective study. Gastroenterology. 2015;148:1340.10.1053/j.gastro.2015.03.006 ↗
78. Li X, Tang J, Mao Y. Incidence and risk factors of drug-induced liver injury. Liver Int. 1999;2022:42.
79. Hu C, Li L. Improvement of mesenchymal stromal cells and their derivatives for treating acute liver failure. J Mol Med. 2019;97:1065.10.1007/s00109-019-01804-x ↗
80. Hwang Y, Kim JC, Tae G. Significantly enhanced recovery of acute liver failure by liver targeted delivery of stem cells via heparin functionalization. Biomaterials. 2019;209:67.10.1016/j.biomaterials.2019.04.019 ↗
81. Liu M, Yang J, Hu W, Zhang S, Wang Y. Superior performance of co-cultured mesenchymal stem cells and hepatocytes in poly(lactic acid-glycolic acid) scaffolds for the treatment of acute liver failure. Biomed Mater. 2016;11: 015008.10.1088/1748-6041/11/1/015008 ↗
82. Wang J, Ren H, Yuan X, Ma H, Shi X, Ding Y. Interleukin-10 secreted by mesenchymal stem cells attenuates acute liver failure through inhibiting pyroptosis. Hepatol Res. 2018;48:E194.10.1111/hepr.12969 ↗
83. Gupta S, Sharma A, Paneerselvan S, Kandoi S, Patra B, Bishi DK, Verma RS. Generation and transplantation of hepatocytes-like cells using human origin hepatogenic serum for acute liver injury treatment. Xenotransplantation. 2022;29: e12730.10.1111/xen.12730 ↗
84. Milewski K, Czarnecka AM, Albrecht J, Zielinska M. Decreased expression and uncoupling of endothelial nitric oxide synthase in the cerebral cortex of rats with thioacetamide-induced acute liver failure. Int J Mol Sci. 2021;22:6662.10.3390/ijms22136662 ↗
85. Temnov AA, Rogov KA, Sklifas AN, Klychnikova EV, Hartl M, Djinovic-Carugo K, Charnagalov A. Protective properties of the cultured stem cell proteome studied in an animal model of acetaminophen-induced acute liver failure. Mol Biol Rep. 2019;46:3101.10.1007/s11033-019-04765-z ↗
86. Yan M, Huo Y, Yin S, Hu H. Mechanisms of acetaminophen-induced liver injury and its implications for therapeutic interventions. Redox Biol. 2018;17:274.10.1016/j.redox.2018.04.019 ↗
87. Dargue R, Zia R, Lau C, Nicholls AW, Dare TO, Lee K, Jalan R, Coen M, Wilson ID. Metabolism and effects on endogenous metabolism of paracetamol (acetaminophen) in a porcine model of liver failure. Toxicol Sci. 2020;175:87.10.1093/toxsci/kfaa023 ↗
88. Gonzalez R, Ferrin G, Hidalgo AB, Ranchal I, Lopez-Cillero P, Santos-Gonzalez M, Lopez-Lluch G, Briceno J, Gomez MA, Poyato A, Villalba JM, Navas P, De La Mata M, Muntane J. N-Acetylcysteine, coenzyme Q10 and superoxide dismutase mimetic prevent mitochondrial cell dysfunction and cell death induced by d-galactosamine in primary culture of human hepatocytes. Chem Biol Interact. 2009;181:95.10.1016/j.cbi.2009.06.003 ↗
89. Choi JH, Kang JW, Kim DW, Sung YK, Lee SM. Protective effects of Mg-CUD against d-galactosamine-induced hepatotoxicity in rats. Eur J Pharmacol. 2011;657:138.10.1016/j.ejphar.2011.01.030 ↗
90. Feng L, Cai L, He GL, Weng J, Li Y, Pan MX, Jiang ZS, Peng Q, Gao Y. Novel d-galactosamine-induced cynomolgus monkey model of acute liver failure. World J Gastroenterol. 2017;23:7572.10.3748/wjg.v23.i42.7572 ↗
91. Shi D, Zhang J, Zhou Q, Xin J, Jiang J, Jiang L, Wu T, Li J, Ding W, Li J, Sun S, Li J, Zhou N, Zhang L, Jin L, Hao S, Chen P, Cao H, Li M, Li L, Chen X, Li J. Quantitative evaluation of human bone mesenchymal stem cells rescuing fulminant hepatic failure in pigs. Gut. 2017;66:955.10.1136/gutjnl-2015-311146 ↗
92. Lin CX, Wang XE, Liu NY, Peng Q, Li Y, Zhang L, Gao Y. Characterization and evaluation of HGF-loaded PLGA nanoparticles in a CCl4-induced acute liver injury mouse model. J Nanomater. 2019;2019:7936143.10.1155/2019/7936143 ↗
93. Unsal V, Cicek M, Sabancilar I. Toxicity of carbon tetrachloride, free radicals and role of antioxidants. Rev Environ Health. 2021;36:279.10.1515/reveh-2020-0048 ↗
94. Nobakht Lahrood F, Saheli M, Farzaneh Z, Taheri P, Dorraj M, Baharvand H, Vosough M, Piryaei A. Generation of transplantable three-dimensional hepatic-patch to improve the functionality of hepatic cells in vitro and in vivo. Stem Cells Dev. 2020;29:301.10.1089/scd.2019.0130 ↗
95. Sepehrinezhad A, Shahbazi A, Sahab Negah S, Joghataei MT, Larsen FS. Drug-induced-acute liver failure: a critical appraisal of the thioacetamide model for the study of hepatic encephalopathy. Toxicol Res. 2021;8:962.
96. Kang HT, Jun DW, Jang K, Hoh JK, Lee JS, Saeed WK, Chae YJ, Lee JH. Effect of stem cell treatment on acute liver failure model using scaffold. Dig Dis Sci. 2019;64:781.10.1007/s10620-018-5363-2 ↗
97. Yang Q, Shi Y, Yang Y, Chen Z. Deactivation and apoptosis of hepatic macrophages are involved in the development of concanavalin A-induced acute liver failure. Mol Med Rep. 2013;8:757.10.3892/mmr.2013.1575 ↗
98. Liu W, Jing ZT, Wu SX, He Y, Lin YT, Chen WN, Lin XJ, Lin X. A novel AKT activator, SC79, prevents acute hepatic failure induced by Fas-mediated apoptosis of hepatocytes. Am J Pathol. 2018;188:1171.10.1016/j.ajpath.2018.01.013 ↗
99. Rahbari NN, Garden OJ, Padbury R, Brooke-Smith M, Crawford M, Adam R, Koch M, Makuuchi M, Dematteo RP, Christophi C, Banting S, Usatoff V, Nagino M, Maddern G, Hugh TJ, Vauthey JN, Greig P, Rees M, Yokoyama Y, Fan ST, Nimura Y, Figueras J, Capussotti L, Buchler MW, Weitz J. Posthepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery (ISGLS). Surgery. 2011;149:713.10.1016/j.surg.2010.10.001 ↗
100. Hefler J, Marfil-Garza BA, Pawlick RL, Freed DH, Karvellas CJ, Bigam DL, Shapiro AMJ. Preclinical models of acute liver failure: a comprehensive review. PeerJ. 2021;9: e12579.10.7717/peerj.12579 ↗